Daniel E. Singer
Impact in
- Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
- Cardiology and Cardiovascular Medicine top 0.02%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Atrial Fibrillation Management and Outcomes 231
- Cardiac Arrhythmias and Treatments 35
- Antiplatelet Therapy and Cardiovascular Diseases 18
-
- Venous Thromboembolism Diagnosis and Management 33
- Co-authors
- Yuchiao Chang (74 shared papers)Alan S. Go (73 shared papers)Elaine M. Hylek (42 shared papers)Lori E. Henault (9 shared papers)Joe V. Selby (6 shared papers)Jonathan L. Halperin (58 shared papers)Kenneth Mahaffey (99 shared papers)Jonathan Paul Piccini (99 shared papers)
- Journals
- Journal of the American College of Cardiology (29 papers)Journal of the American Heart Association (26 papers)American Heart Journal (25 papers)Circulation (22 papers)The American Journal of Medicine (19 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Daniel E. Singer
435 papers receiving 54.4k citations
Daniel E. Singer's Hit Papers
Peers
Comparison fields: 5 of 200
- Internal Medicine 7.9k
- Cardiology and Cardiovascular Medicine 31.9k
- Epidemiology 8.7k
- Family Practice 452
- Critical Care and Intensive Care Medicine 938
Countries citing papers authored by Daniel E. Singer
This map shows the geographic impact of Daniel E. Singer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Singer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Singer more than expected).
Fields of papers citing papers by Daniel E. Singer
This network shows the impact of papers produced by Daniel E. Singer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Singer. The network helps show where Daniel E. Singer may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel E. Singer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 450 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Hit paper breakdown → | 2011 | 7437 |
| 2 | Prevalence of Diagnosed Atrial Fibrillation in Adults Hit paper breakdown → | 2001 | 5183 |
| 3 | A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia Hit paper breakdown → | 1997 | 3777 |
| 4 | Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population Hit paper breakdown → | 2013 | 1056 |
| 5 | Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation Hit paper breakdown → | 2003 | 1007 |
| 6 | Antithrombotic Therapy for Atrial Fibrillation Hit paper breakdown → | 2012 | 758 |
| 7 | A New Risk Scheme to Predict Warfarin-Associated Hemorrhage Hit paper breakdown → | 2011 | 724 |
| 8 | The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk Hit paper breakdown → | 2009 | 707 |
| 9 | Assessing Health-Related Quality of Life in Patients With Sciatica Hit paper breakdown → | 1995 | 671 |
| 10 | An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation Hit paper breakdown → | 1996 | 629 |
| 11 | Antithrombotic Therapy in Atrial Fibrillation Hit paper breakdown → | 2008 | 617 |
| 12 | The Clinical Information Value of the Glycosylated Hemoglobin Assay Hit paper breakdown → | 1984 | 594 |
| 13 | 2003 | 593 | |
| 14 | Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation Hit paper breakdown → | 2002 | 585 |
| 15 | The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation Hit paper breakdown → | 2009 | 551 |
| 16 | 2004 | 509 | |
| 17 | 1999 | 502 | |
| 18 | Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment Hit paper breakdown → | 2011 | 486 |
| 19 | 2005 | 483 | |
| 20 | Mortality Among Homeless Adults in Boston Hit paper breakdown → | 2013 | 455 |
About Daniel E. Singer
Daniel E. Singer is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Epidemiology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism, having authored 450 papers that have together received 57.8k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (231 papers), Cardiac Arrhythmias and Treatments (35 papers), Venous Thromboembolism Diagnosis and Management (33 papers), Acute Ischemic Stroke Management (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Smoking Behavior and Cessation (17 papers), Spine and Intervertebral Disc Pathology (17 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). The work is most often cited by research in Internal Medicine (7.9k citations), Cardiology and Cardiovascular Medicine (31.9k citations), Epidemiology (8.7k citations), Family Practice (452 citations) and Critical Care and Intensive Care Medicine (938 citations). Daniel E. Singer has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Yuchiao Chang, Alan S. Go, Elaine M. Hylek, Lori E. Henault, Joe V. Selby, Jonathan L. Halperin, Kenneth Mahaffey, Jonathan Paul Piccini, Kathleen A. Phillips and Steven J. Atlas. Their work appears in journals such as Journal of the American College of Cardiology, Journal of the American Heart Association, American Heart Journal, Circulation and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.